Adaptive Phage Therapeutics
Bethesda
About Adaptive Phage Therapeutics
Adaptive Phage Therapeutics provides therapeutic services intended to treat multi-drug resistant pathogenic bacteria. Its services are provided using clinical and therapeutic technology that matches phages to patient-specific bacterial infections, enabling medical researchers to develop drugs that can detect and eliminate multi-drug resistant bacteria.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $131.7M
- Funding stage: M&A
- Last round: Series B (Jun 2023)
- Website: aphage.com
- Phone: 2408992532
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/adaptive-phage-therapeutics-98074 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.